Navigation Links
Prominent 'Chick Lit' Novelist Laura Zigman Joins HealthCentral's MyBreastCancerNetwork.com as Expert
Date:10/31/2007

ARLINGTON, Va., Oct. 31 /PRNewswire-USNewswire/ -- The HealthCentral Network, Inc. (http://www.HealthCentral.com) today announced that breast cancer survivor Laura Zigman, a best-selling author regarded as the progenitor of the "Chick Lit" genre, will join MyBreastCancerNetwork.com as an expert.

Zigman's weekly blogs will approach breast cancer from the everyday woman's point of view, with the goal of making life with cancer approachable and, at times, even funny. The 45-year-old novelist will regularly appear as a comic strip character in her blog, living out her cancer experience in a bright, visual format.

Zigman's graphic blogs will combine the visual impact of graphic novels like Cancer Vixen with the near-instant gratification of Zigman herself responding to comments from the community. Her responsiveness in the social networking sphere was featured recently in the New York Times Sunday Book Review, with the author using her MySpace page to interact with her readers in "den mother" fashion.

Zigman's refreshing and supportive responsiveness will add to an already vibrant network of experts and community members who share their personal stories of living with an often life-changing condition. MyBreastCancerNetwork.com also provides targeted clinical information and resources on treating and managing the condition.

"Those who have breast cancer are desperate to know the truth about what to expect," Zigman said. " I'm thrilled to have a chance to be a part of MyBreastCancerNetwork.com -- a site I wish I had known about last year for the depth of information as well as for the sense of community -- because it's where you will hear the truth."

"Laura Zigman's work supporting breast cancer sufferers and survivors makes her an excellent addition to the HealthCentral team," said Chris Schroeder, CEO and President of The HealthCentral Network. "Laura's expertise and dedication to community will be an invaluable asset to those struggling with breast cancer."

Zigman has written several novels, including Animal Husbandry, which became a national bestseller and was the basis for the 2000 movie Someone Like You.

MyBreastCancerNetwork.com was recently honored for creative excellence, receiving the Silver Award from the International Academy of the Visual Arts W3 Awards.

About The HealthCentral Network

The HealthCentral Network, Inc. (http://www.healthcentral.com) is a new and unique online offering, comprised of over 30 general health and highly specific condition and wellness web properties, each committed to offering a voice in everyday and personal language people can understand and connect with at critical points in their lives. Each site provides timely, interactive, in-depth and trusted medical information (from Harvard Health among others), and connections to leading experts and thousands of people who share their related experiences and inspiration.

The HealthCentral Network recently launched personal health tools including the most comprehensive web solution for caregivers managing their communities of friends and families (http://www.carecentral.com). The company also produces the nationally syndicated television show, "Medical Breakthroughs with Dr. Dean Edell," and has a library of nearly 1,000 short-form, condition-specific videos throughout its network.

The HealthCentral Network was acquired in 2005 by Polaris Ventures, Sequoia Capital, The Carlyle Group and Allen & Company, and has built a management team that combines decades of experience in interactive media and medical, science and news journalism. The company received top recognition from The International Health and Medical Media Awards with a 2006 FREDDIE Award for MyDiabetesCentral.com and the Health Care Standard of Excellence WebAward from the Web Marketing Association.


'/>"/>
SOURCE The HealthCentral Network
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. New Study In Australia Shows Heart Disease More Prominent Among The Poor
2. Medical intervention , a prominent cause of emergency caesarians
3. Jolies Slimmer Arms Shows Her Prominent Veins
4. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
5. Vaccine To Stop the Spread of Chickenpox
6. Chickens Found To Have High Levels of Arsenic
7. The Effectiveness Of Chickenpox Vaccine Questioned
8. Chicken-Pox vaccine not fool proof
9. Chicken pox beholds brain tumour risk
10. Super Bugs Contaminate UK Chickens
11. Chicken Pox Hospitalizations Are Becoming Less
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... A study by the founder of ... colleague, Sudeep Roy, MD, was recently published in the American Journal of Cosmetic ... details Drs. Buckingham and Roy’s study on the use of Electro Lube during the ...
(Date:3/27/2017)... ... March 27, 2017 , ... Buzzies parent company, The TouchPoint ... Rent the Runway Foundation and UBS’ Project Entrepreneur. Mayo will present her pitch about ... , Project Entrepreneur’s second annual venture competition ignites bold ideas by providing women ...
(Date:3/27/2017)... Niles, IL (PRWEB) , ... March 27, 2017 ... ... testing systems, recently received the CE Certificate of Conformity for the Smart System® ... meet or exceed the highest industry standards and specifications such as ANSI, ISO ...
(Date:3/27/2017)... ... March 27, 2017 , ... American Veterinarian™, ... coverage on veterinary medicine, announces the launch of Veterinarian’s Money Digest™, a business ... the April edition of American Veterinarian™. , “We look forward to ...
(Date:3/27/2017)... ... March 27, 2017 , ... Metabolism and hormone ... Women’s Excellence will help patients lose weight and keep it off. , The ... at Women's Excellence will measure BMI, body fat composition, and Calcium and Magnesium ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), a ... liver diseases in children, today reported financial results ... December 31, 2016 and provided an update on ... to make progress during the fourth quarter of ... our non-human primate safety study, and with our lead ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... offering. ... The Cell Therapy Manufacturing Market, 2017-2027 report provides an extensive ... and focuses both on contract manufacturers and cell therapy developers ... as viable alternatives to conventional treatment options. ...
Breaking Medicine Technology: